Simon G. Royce
99 Commercial Road
Melbourne, VIC 3004, Australia
Melbourne, VIC 3004, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 69 publications
Therapeutic targeting of bleomycin-induced pulmonary fibrosis by human bone marrow mesenchymal stem cell-derived extracellular vesicles and/or pirfenidone: Impact of sex in mature adult mice.
Journal: British journal of pharmacology
Published: December 16, 2025
Lung-specific TGFβ overexpression increases airway fibrosis and airway contractility in transgenic mice.
Journal: American journal of physiology. Lung cellular and molecular physiology
Published: June 30, 2025
Human bone marrow mesenchymal stem cell-derived extracellular vesicles induce inverse dose-dependent anti-fibrotic effects in human myofibroblast cultures and bleomycin-injured mice with pulmonary fibrosis.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 24, 2025
LPS Increases Artery but Not Airway Contraction in Precision-Cut Lung Slices from a Mouse Model of Acute Respiratory Distress Syndrome.
Journal: American journal of respiratory cell and molecular biology
Published: December 19, 2024
The novel AT2 receptor ligand, β-Pro7 Ang III, induces equivalent anti-fibrotic effects to Compound 21 but broader anti-fibrotic effects than pirfenidone in mice with bleomycin-induced pulmonary fibrosis.
Journal: Clinical science (London, England : 1979)
Published: December 18, 2024
Aerosol Delivery of Palivizumab in a Neonatal Lamb Model of Respiratory Syncytial Virus Infection.
Journal: Viruses
Published: October 25, 2023
The small-molecule formyl peptide receptor biased agonist, compound 17b, is a vasodilator and anti-inflammatory in mouse precision-cut lung slices.
Journal: British journal of pharmacology
Published: September 23, 2022
Comparative Study of Ectopic Lymphoid Aggregates in Sheep and Murine Models of Bleomycin-Induced Pulmonary Fibrosis.
Journal: Canadian respiratory journal
Published: September 12, 2022
Sulforaphane prevents and reverses allergic airways disease in mice via anti-inflammatory, antioxidant, and epigenetic mechanisms.
Journal: Cellular and molecular life sciences : CMLS
Published: July 01, 2022
Analysis and comparison of anti-RBD neutralizing antibodies from AZD-1222, Sputnik V, Sinopharm and Covaxin vaccines and its relationship with gender among health care workers.
Journal: Immunity & ageing : I & A
Published: May 23, 2022
The high level of adherence to personal protective equipment in health care workers efficiently protects them from COVID-19 infection.
Journal: Work (Reading, Mass.)
Published: August 23, 2021
Pulmonary myeloid cell uptake of biodegradable nanoparticles conjugated with an anti-fibrotic agent provides a novel strategy for treating chronic allergic airways disease.
Journal: Biomaterials
Published: October 19, 2020
Last Updated: 09/26/2026